Lipidomics and proteomics in MASLD: reading the molecular script toward precision therapeutics
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disorder characterized by complex metabolic, inflammatory, and fibrogenic interactions. Advances in lipidomics and proteomics have substantially refine... ...